IDO1 and hepatocellular carcinoma: In the present study, we investigated the role of IDO in diethylnitrosamine (DEN)-induced liver carcinogenesis by using IDO-deficient mice to obtain preclinical data for therapy and/or chemoprevention of HCC by modulating IDO expression.